Back to search

Article

Tissue-based methylation testing as a predictor of clinical regression in patients with high- grade cervical intraepithelial neoplasia (CIN2/3)

2026-08-21

Abstract excerpt

<title>Abstract</title> <p> Introduction. High-grade cervical intraepithelial neoplasia (CIN2/3) exhibit heterogeneous clinical behavior, ranging from spontaneous regression to progression to cancer. Methylation testing of <italic>FAM19A4/miR124-2</italic> genes in clinician- and self-collected cervical scrapes has demonstrated to predict clinical regression in women with untreated CIN2/3 (CONCERVE study). Th...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a2d429fe-93a2-5beb-8d82-0277e54df865
DOI
10.21203/rs.3.rs-10358193/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Tissue-based methylation testing as a predictor of clinical regression in patients with high- grade cervical intraepithelial neoplasia (CIN2/3)DOI 10.21203/rs.3.rs-10358193/v1
Clinical Regression of High-Grade Cervical Intraepithelial Neoplasia Is Associated With Absence of FAM19A4/miR124-2 DNA Methylation (CONCERVE Study).Semantic proximity
FAM19A4/miR124-2 Methylation Testing and Human Papillomavirus (HPV) 16/18 Genotyping in HPV-Positive Women Under the Age of 30 Years.Semantic proximity
Cervical cancer risk in HPV-positive women after a negative FAM19A4/mir124-2 methylation test: A post hoc analysis in the POBASCAM trial with 14 year follow-up.Semantic proximity
FAM19A4/miR124‐2 methylation in invasive cervical cancer: A retrospective cross‐sectional worldwide studySemantic proximity
Validation of the FAM19A4/mir124-2 DNA methylation test for both lavage- and brush-based self-samples to detect cervical (pre)cancer in HPV-positive women.Semantic proximity
Evaluation of CIN2/3 Lesion Regression in GynTect® DNA Methylation-Marker-Negative Patients in a Longitudinal StudySemantic proximity
Discovery of new methylation markers to improve screening for cervical intraepithelial neoplasia grade 2/3Semantic proximity
Methylation Analysis to Detect CIN3+ in High-Risk Human Papillomavirus-Positive Self-Samples From the Population-Based Cervical Cancer Screening ProgramSemantic proximity
Methylation marker analysis and HPV16/18 genotyping in high-risk HPV positive self-sampled specimens to identify women with high grade CIN or cervical cancer.Semantic proximity
Discovery and technical validation of high-performance methylated DNA markers for the detection of cervical lesions at risk of malignant progression in low- and middle-income countriesSemantic proximity
Virtues and Weaknesses of DNA Methylation as a Test for Cervical Cancer PreventionSemantic proximity
Comparing the performance of FAM19A4 methylation analysis, cytology and HPV16/18 genotyping for the detection of cervical (pre)cancer in high-risk HPV-positive women of a gynecologic outpatient population (COMETH study).Semantic proximity
Select a neighboring publication to make it the new centre.